IXJ PDS
The Product Disclosure Statement (PDS) explains the fees, tax status and some of the risks.
Menu
The iShares IXJ ETF provides investors with a targeted exposure to over 100 global healthcare companies. This includes companies in the pharmaceutical, biotechnology, and medical device space.
IXJ invests in a portfolio of global healthcare companies, including leading brands like Johnson & Johnson, CSL and Glaxosmithkline. Trying to replicate this exposure to healthcare stocks yourself would be time-consuming and expensive, so IXJ could be a solution for investors looking for a targeted exposure to this sector.
IXJ could be used by investors to gain a tactical exposure to the global healthcare sector, and has a strong geographical exposure to the US market. This ETF aims to track the S&P Global 1200 Healthcare Sector Index, before fees and expenses.
To invest in any ASX ETF, you need to use create your own broker account and choose from over 400 ETFs.
But why bother do that when you can get everything done for you – for a simple, low, fee?
We manage ETF portfolios on behalf of 250+ Australian investors, with over $20 million invested.
Simple. Low cost. Transparent. Professional.
It’s called Rask Invest.
Click the button to discover the ETFs we own, and how it works.
*The warnings on this page are applied by our ETF research team. Please know that these warnings are based on quantitative metrics and our internal methodology. These risks are not exhaustive and therefore they should not be relied upon. Always read the PDS of the function and speak to your financial adviser before acting on this information.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.
© Rask Australia 2024
